Exocrine pancreatic insufficiency in dogs

Veterinary Clinics of North America - Small Animal Practice

Volumn 33, Issue 5, 2003, Pages 1165-1179

  Westermarck, Elias ^a   Wiberg, Maria ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CIMETIDINE; ELASTASE; HISTAMINE H2 RECEPTOR ANTAGONIST; PANCREAS ENZYME; TRYPSIN;

ACINAR CELL; ANAMNESIS; AUTOIMMUNITY; CLINICAL FEATURE; DEFECATION DISORDER; DIARRHEA; DIET THERAPY; DOG DISEASE; ECZEMA; ENZYME ACTIVITY; ENZYME REPLACEMENT; FECES ANALYSIS; FLATULENCE; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INHERITANCE; MORPHOLOGY; NONHUMAN; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION TEST; PANCREAS SECRETION; PROGNOSIS; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; REVIEW; WEIGHT REDUCTION;

CANIS FAMILIARIS;

EID: 0141921465     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00057-3     Document Type: Review

References (55)

1. Freudiger U. Die Erkrankungen des exocrinen Pankreas des Hundes. Kleintierpraxis 1971;16:201-28.
2. Wiberg ME. Pancreatic acinar atrophy in German shepherd dogs and rough-coated Collies. Etiopathogenesis and response to long-term enzyme replacement treatment [PhD thesis]. Helsinki: Helsinki University; 2003.
3. Williams DA. Exocrine pancreatic disease. In: Ettinger SJ, Feldman EC, editors. Textbook of veterinary internal medicine: diseases of the dog and cat. 5th edition. Philadelphia: WB Saunders; 2000. p. 1345-67.
4. Dimagno EP, Go VLW, Summerskill WHJ. Relations between pancreatic enzyme outputs and malabsorption of severe pancreatic insufficiency. N Engl J Med 1973;288:813-5.
5. Westermarck E, Sandholm M. Faecal hydrolyase activity as determined by radial enzyme diffusion: a new method for detecting pancreatic dysfunction in the dog. Res Vet Sci 1980;28:341-6.
6. Geyer S, Bibrack BR, Hänichen T. Zur Klinik und pathologie von Pankreaserkrankungen beim Hund. Kleintierpraxis 1968;13:17-24.
7. Rimaila-Pärnänen E, Westermarck E. Pancreatic degenerative atrophy and chronic pancreatitis in dogs. A comparative study of 60 cases. Acta Vet Scand 1982;23:400-6.
8. Thordal-Christensen AA, Coffin DL. Pancreatic disease in the dog. Nord Vet Med 1956; 8:89-114.
9. Durie PR. Inherited causes of exocrine pancreatic dysfunction. Can J Gastroenterol 1997; 11:145-52.
10. Säteri H. Investigations on the exocrine pancreatic function in dogs suffering from chronic exocrine pancreatic insufficiency. Acta Vet Scand 1975;53:1-86.
11. Boari A, Williams DA, Famigli-Bergamini P. Observations on exocrine pancreatic insufficiency in a family of English Setter dogs. J Small Anim Pract 1994;35:247-50.
12. Neiger R, Bornand Jaunin VB, Boujon CE. Exocrine pancreatic insufficiency combined with insulin-dependent diabetes mellitus in a juvenile German Shepherd Dog. J Small Anim Pract 1996;37:344-9.
13. Hill FWG, Osborne AD, Kidder DE. Pancreatic degenerative atrophy in dogs. J Comp Pathol 1971;81:321-30.
14. Westermarck E, Batt RM, Vaillant C, Wiberg M. Sequential study of pancreatic structure and function during development of pancreatic acinar atrophy in a German Shepherd Dog. Am J Vet Res 1993a;54:1088-94.
15. Fell BF, King TP, Davies NT. Pancreatic atrophy in copper-deficient rats: histochemical and ultrastructural evidence of a selective effect on acinar cells. Histochem J 1982;14: 665-80.
16. Tanaka T, Ichiba Y, Miura Y, et al. Canine model of chronic pancreatitis due to chronic ischemia. Digestion 1994;55:86-9.
17. Watanabe S, Abe K, Anbo Y, et al. Changes in the mouse exocrine pancreas after pancreatic duct ligation: a qualitative and quantitative histological study. Arch Histol Cytol 1995;58:365-74.
18. Räihä M, Westermarck E. The signs of pancreatic degenerative atrophy in dogs and the role of external factors in the etiology of the disease. Acta Vet Scand 1989;30:447-52.
19. Westermarck E, Pamilo P, Wiberg M. Pancreatic degenerative atrophy in the Collie breed: a hereditary disease. J Vet Med 1989;36:549-54.
20. Williams DA, Batt RM. Sensitivity and specificity of radioimmunoassay of serum trypsin-like immunoreactivity for the diagnosis of canine exocrine pancreatic insufficiency. J Am Vet Med Assoc 1988;192:195-200.
21. Moeller EM, Steiner JM, Clark LA, et al. Inheritance of pancreatic acinar atrophy in German Shepherd Dogs. Am J Vet Res 2002;63:1429-34.
22. Westermarck E. Hereditary nature of canine pancreatic degenerative atrophy in the German Shepherd Dog. Acta Vet Scand 1980;21:389-94.
23. Wiberg ME, Nurmi A-K, Westermarck E. Serum trypsin-like immunoreactivity measurement for the diagnosis of subclinical exocrine pancreatic insufficiency in dogs. J Vet Intern Med 1999a;13:426-32.
24. Wiberg ME, Saari SAM, Westermarck E. Exocrine pancreatic atrophy in German Shepherd Dogs and Rough-Coated Collies: an end-result of lymphocytic pancreatitis. Vet Pathol 1999b;36:530-41.
25. Wiberg ME, Saari SAM, Westermarck E, et al. Cellular and humoral immune responses in atrophic lymphocytic pancreatitis in German Shepherd Dogs and Rough-Coated Collies. Vet Immunol Immunopathol 2000;76:103-15.
26. Beale K. Canine immune-mediated thyroiditis. Vet Med Rep 1991;3:123-30.
27. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunology 1993;14:426-30.
28. Simpson KW, Cobb MA. Investigation of the relationship of circulating anti-pancreatic antibodies to exocrine pancreatic insufficiency in dogs. Eur J Comp Gastroenterol 1998; 3:37-42.
29. Reidelberg RD, O'Rourke M, Durie PR, et al. Effect of food intake and cholecystokinin on plasma trypsinogen levels in dogs. Am J Physiol 1984;246(5 Part 1):G543-9.
30. Geokas MC, Reidelberg R, O'Rourke M, et al. Plasma pancreatic trypsinogens in chronic renal failure and after nephrectomy. Am J Physiol 1982;242:G177-82.
31. Hill FWG, Kidder DE. The estimation of daily fecal trypsin levels in dogs as an indicator of gross pancreatic exocrine insufficiency. J Small Anim Pract 1970;11:191-5.
32. Westermarck E. The diagnosis of pancreatic degenerative atrophy in dogs - a practical method. Acta Vet Scand 1982;23:197-203.
33. Spillmann T, Wittker A, Teigelkamp S, et al. An immunoassay for canine pancreatic elastase 1 as an indicator for exocrine pancreatic insufficiency in dogs. J Vet Diagn Invest 2001b;13:468-74.
34. Löser C, Mölgaard A, Fölsch UR. Faecal elastase: a novel, highly sensitive and specific tubeless pancreatic function test. Gut 1996;39:580-6.
35. Spillmann T, Wiberg ME, Teigelkamp S, et al. Canine faecal pancreatic elastase (cE1) in dogs with clinical exocrine pancreatic insufficiency, normal dogs and dogs with chronic enteropathies. Eur J Comp Gastroenterol 2001a;2:5-10.
36. Wiberg ME, Westermarck E. Subclinical exocrine pancreatic insufficiency in dogs. J Am Vet Med Assoc 2002;220:1183-7.
37. Wiberg ME, Westermarck E, Spillmann T, et al. Canine faecal pancreatic elastase (cE1) for the diagnosis of subclinical exocrine pancreatic insufficiency in dogs. Eur J Comp Gastroenterol 2001;2:21-5.
38. Harmoinen J, Saari S, Rinkinen M, et al. Evaluation of pancreatic forceps biopsy by laparoscopy in healthy Beagles. Vet Ther 2002;3:31-6.
39. Spillmann T, Moritz A, Burkhardt E. Die Stellung der Laparoskopie in der Diagnostik von Pankreaserkrankungen des Hundes. Tierarztl Prax 2000;28(K):349 55.
40. Twedt DC. Laparoscopy of the liver and pancreas. In: Tams TR, editor. Small animal endoscopy. 2nd edition. St. Louis: Mosby; 1999. p. 377-91.
41. Westermarck E. Treatment of pancreatic degenerative atrophy with raw pancreas homogenate and various enzyme preparations. J Am Vet Med Assoc 1987;34:728-33.
42. Wiberg ME, Lautala H-M, Westermarck E. Response to long-term enzyme replacement treatment in dogs with exocrine pancreatic insufficiency. J Am Vet Med Assoc 1998;1: 86-90.
43. Marvola M, Heinmäki J, Westermarck E. The fate of single-unit enteric-coated drug products in the stomach of a dog. Acta Pharm Fenn 1986;95:59-70.
44. Hall EJ, Bond PM, McLean C, et al. A survey of the diagnosis and treatment of canine exocrine pancreatic insufficiency. J Small Anim Pract 1991;32:613-9.
45. Simpson JW, Maskell IE, Quigg J, et al. The long-term management of canine exocrine pancreatic insufficiency. J Small Anim Pract 1994;35:133-8.
46. Westermarck E, Wiberg M, Junttila J. Role of feeding in the treatment of the dogs with pancreatic degenerative atrophy. Acta Vet Scand 1990;31:325-31.
47. Westermarck E, Junttila J, Wiberg M. The role of low dietary fat in the treatment of dogs with exocrine pancreatic insufficiency. Am J Vet Res 1995;56:600-5.
48. Rutz GM, Steiner JM, Bauer JE, et al. The effect of dietary medium chain triglycerides on dogs with exocrine pancreatic insufficiency [abstract]. J Vet Intern Med 2001;15:319.
49. Batt RM, Morgan JO. Role of serum folate and vitamin B12 concentrations in the differentiation of small intestinal abnormalities in the dog. Res Vet Sci 1982;32:17-22.
50. Simpson KW, Morton DB, Batt RM. Effect of exocrine pancreatic insufficiency on cobalamin absorption in dogs. Am J Vet Res 1989;50:1233-6.
51. Williams DA, Batt RM, McLean L. Bacterial overgrowth in the duodenum of dogs with exocrine pancreatic insufficiency. J Am Vet Med Assoc 1987;191:201-6.
52. Westermarck E, Myllys V, Aho M. Effect of treatment on the jejunal and colonic bacterial flora of dogs with exocrine pancreatic insufficiency. Pancreas 1993b;8:559-62.
53. Simpson KW, Batt RM, Jones D, et al. Effects of exocrine pancreatic insufficiency and replacement therapy on the bacterial flora of the duodenum in dogs. Am J Vet Res 1990;51:203 6.
54. Batt RM, Horadagoda NU, McLean L, et al. Identification and characterization of a pancreatic intrinsic factor in the dog. Am J Physiol 1989;256:517-23.
55. Westermarck E, Rimaila-Pärnänen E. Mesenteric torsion in dogs with exocrine pancreatic insufficiency: 21 cases (1978-1987). J Am Vet Med Assoc 1989a;195:1404-6.